Akorn Appoints Duane A. Portwood as Chief Financial Officer
October 13, 2015 17:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Duane A. Portwood, 49, will join Akorn as...
Akorn Launches Myorisan(TM) 30 mg Capsules
September 28, 2015 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the recently-approved 30 mg strength...
Akorn Launches Doxercalciferol Injection
September 21, 2015 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Doxercalciferol Injection Solution, 4...
Akorn Launches Two Additional Promethazine Syrup Formulations
September 17, 2015 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Sept. 17, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Promethazine Hydrochloride and...
Akorn Receives NASDAQ Delinquency Notice
August 14, 2015 16:01 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced that, as expected, it has received a notice from the NASDAQ Staff stating that the Company is not in...
Akorn Appoints Randy Pollard as Interim Chief Financial Officer
August 04, 2015 16:35 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced the appointment of Randall Pollard as Chief Accounting Officer and Interim Chief Financial Officer. Mr....
Akorn Announces Nasdaq's Acceptance of Its Plan to Regain Compliance
July 15, 2015 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., July 15, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), today announced that the Nasdaq Stock Market has accepted the company's plan to regain compliance with Nasdaq Listing...
Akorn Launches Acetylcysteine Injection
July 08, 2015 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., July 8, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched Acetylcysteine Injection 6 g/30 mL in 30...
Akorn Receives NASDAQ Delinquency Notice
May 18, 2015 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., May 18, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) today announced it has received a notice from NASDAQ stating the Company is not in compliance with Listing Rule 5250(c)(1)...
Akorn Announces Recent Executive Appointments
April 27, 2015 07:00 ET
|
Akorn, Inc.
- New EVP Sales and Marketing to Oversee All Akorn Commercial Operations -
- Newly Appointed Controller Strengthens Akorn's Finance Team -
- New EVP Pharmaceutical Operations to Oversee Supply...